- Contract research organizations
- Asia
- China
- Hangzhou Tigermed Consulting Co
Hangzhou Tigermed Consulting Co in China
E-mail: bd@tigermed.net
Addresses:
-
Fl.15,Dongguan Plaza,No.618 Jiangnan, Avenue,Binjiang,District,Hangzhou,P.R.China,Code:310053
Phone: 86-571-28887227
Fax: 86-571-88211196
-
Fl.16, Huawen International Building,No.999 West Zhongshan Road,Changning District, Shanghai,P.R.China,Code:200051
Web: https://www.tigermed.net/
Phone: 86-21-32503700
Fax: 86-21-32503707
-
No.28 Huixin Road,Nanhu District (South Side of No.599 Yazhong Road,Fl.9,Building 1,Tigermed Plaza)Code:314000
Web: https://www.tigermed.net/
Phone: 86-573-82582315/16/19/25/29/32
Fax: 86-573-83615678
-
Room 2503,Longsheng Mansion,No.23 Hongwu Road,Xinjiekou,Qinhuai District,Nanjing,P.R.China,Code:210008
Web: https://www.tigermed.net/
Phone: 86-25-83557410/83556890/84496861
Fax: 86-25-52400841
-
Room 4B,Yueyun Mansion,No.3 Zhongshan 2th Road,Guangzhou,P.R.China,Code:510080
Web: https://www.tigermed.net/
Phone: 86-20-37667400 020-37613643 020-37621084 020-37613032
Fax: 86-20-37620783
-
Room 808,Union Mansion,No.20 Chaoyangmen Outer Street,Chaoyang District, Beijing,P.R.China,Code:100022
Web: https://www.tigermed.net/
Phone: 86-10-65889599 65885988
Fax: 86-10-65889119
About Hangzhou Tigermed Consulting Co
Hangzhou Tigermed Consulting Co., Ltd(stock symbol: 300347) is a leading Contract Research Organization (CRO) in China dedicated to provide professional full clinical trial services. Since inception in 2004, Tigermed has been committed to accelerating medical product development with costs efficiency and quality. Headquartered in Hangzhou, Tigermed operates 33 subsidiaries, 95 offices across China and 11 overseas offices in Hong Kong China, Taiwan China, USA, Switzerland, Korea, Australia, Japan, Malaysia, Singapore, India and Romania with over 4000 full time staffs. Tigermed has serviced more than 600 local and global clients in the conduct of over 1500 clinical trials. Tigermed is recognized as “The Innovative Clinical CRO” in China,owning to our involvement of over 160 innovative drugs.